[18F]PRIMATX

N/A

Report date: 2025/11/21 17:15:34

NME

Base Information

Drug Name[18F]PRIMATX

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitorsPositron-emission tomography enhancers

TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A